slotkoers
Andere beurzen
|
||
- | - |
|
2023 | TELCON RF PHARMACEUTICAL. Inc. rapporteert resultaten voor het volledige jaar eindigend op 31 december 2022 | CI |
2023 | TELCON RF PHARMACEUTICAL. Inc. Accountant trekt continuïteit in twijfel | CI |
Omzet 2022 | 27,83 mld. 20,15 mln. 0 18,81 mln. | Omzet 2023 | 36,31 mld. 26,29 mln. 0 24,54 mln. | Marktkapitalisatie | 97,67 mld. 70,71 mln. 0 66,03 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | -42,08 mld. -30,47 mln. - -28,45 mln. | Nettowinst (verlies) 2023 | 13,91 mld. 10,07 mln. - 9,4 mln. | EV/omzet 2022 | 4,7 x |
Nettoschuld 2022 | 20,54 mld. 14,87 mln. 0 13,89 mln. | Nettoschuld 2023 | 16,9 mld. 12,24 mln. 0 11,43 mln. | EV/omzet 2023 | 3,16 x |
K/w-verhouding 2022 |
-2,56
x | K/w-verhouding 2023 |
8,52
x | Werknemers | - |
Dividendrendement 2022 * |
-
| Dividendrendement 2023 |
-
| Vrij verhandelbaar | 75,55% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Ji-Hoon Kim
CEO | Chief Executive Officer | 54 | 08-06-18 |
Ji-Han Choi
DFI | Director of Finance/CFO | 48 | 28-03-19 |
Min-Hee Lee
CTO | Chief Tech/Sci/R&D Officer | 46 | 01-05-00 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Gam Sung
BRD | Director/Board Member | 54 | 14-07-16 |
Ji-Han Choi
DFI | Director of Finance/CFO | 48 | 28-03-19 |
Gun Kim
BRD | Director/Board Member | 47 | 28-03-19 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
-5,96% | 191 mld. | |
+48,82% | 109 mld. | |
+81,22% | 73,27 mld. | |
+23,30% | 64,45 mld. | |
+26,75% | 31,12 mld. | |
+16,60% | 20,68 mld. | |
+70,96% | 20,57 mld. | |
+4,26% | 20,52 mld. | |
+5,63% | 16,52 mld. |